ICAQF - Artigos
URI Permanente para esta coleção
Navegar
Navegando ICAQF - Artigos por Assunto "1-phenyl-2-phenoxiethanone"
Agora exibindo 1 - 1 de 1
Resultados por página
Opções de Ordenação
- ItemAntimycobacterial activity of 2-phenoxy-1-phenylethanone, a synthetic analogue of neolignan, entrapped in polymeric microparticles(Informa Healthcare, 2012-03-01) Minarini, Paulo R. R. [UNIFESP]; Souza, Ana O. de; Soares, Edson G.; Barata, Lauro E. S.; Silva, Celio L.; Bentley, Maria Vitoria L. B.; Universidade de São Paulo (USP); Universidade Federal de São Paulo (UNIFESP); Inst Butantan; Universidade Estadual de Campinas (UNICAMP)Conventional treatment of tuberculosis (TB) demands a long course therapy (6 months), known to originate multiple drug resistant strains (MDR-TB), which emphasizes the urgent need for new antituberculous drugs. the purpose of this study was to investigate a novel treatment for TB meant to improve patient compliance by reducing drug dosage frequency. Polymeric microparticles containing the synthetic analogue of neolignan, 1-phenyl-2-phenoxiethanone (LS-2), were obtained by a method of emulsification and solvent evaporation and chemically characterized. Only representative LS-2-loaded microparticles were considered for further studies involving experimental murine TB induced by Mycobacterium tuberculosis H37Rv ATCC 27294. the LS-2-loaded microparticles were spherical in shape, had a smooth wall and showed an encapsulation efficiency of 93% in addition to displaying sustained release. Chemotherapeutic potential of LS-2 entrapped in microparticles was comparable to control groups. These findings are encouraging and indicate that LS-2-loaded microparticles are a potential alternative to conventional chemotherapy of TB.